Clinical trial

Lorcaserin and Behavioral Modification for Overweight and Obesity Management in Chinese Obese Patients

NCT03720574

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-09-17

PhasePHASE3

Study timeline

Study start (actual)2019-09-17Date precision: day

Registry last updated2022-05-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Lorcaserin 10 mg BIDDRUG

Matching Placebo BIDDRUG

Sponsors & collaborators

Kanion & Huawe Medicine Co.,Ltdlead sponsor

Mapped research locations

BeijingBeijing Municipality, China1 ShanghaiShanghai Municipality, China1 NanjingJiangsu, China1 JinanShandong, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03720574 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.